You are here
Family Bank: Global Cord Blood Corp - Beijing
Global Cord Blood Corporation, formerly known as China Cord Blood Corporation (NYSE: CO) is the largest umbilical cord blood banking operator in China. Global Cord Blood Corporation owns the cord blood banking licenses for the provinces of Beijing, Guangdong, Zhejiang, and holds a stake in the province of Shandong.
Labs and Locations
The cord blood bank in Beijing is operated by Beijing Jiachenhong Biological Technologies Co. Ltd., received its cord blood banking license in September 2002.
Location: Yongchang North Road, Daxing, Beijing, China
Listed on the New York Stock Exchange since 2009 (NYSE: CO), Global Cord Blood Corporation was the first cord blood bank licensed in China. Under current PRC government regulations, only one licensed cord blood banking operator is permitted to operate in each of 31 regions. Global Cord Blood Corporation holds 3 exclusive licenses to service the city of Beijing, Guangdong region and Zhejiang region, plus they have an equity stake in Shandong region. The newborn population in their 3 licensed regions is 2.89 million or 45% of the birth population eligible for banking. Together with Shandong region, 73% of the eligible population is covered by Global Cord Blood Corporation banking. As of Feb. 2019 financial report their total subscriber base is 728,279.
Licensing & Accreditation
The Beijing cord blood laboratory achieved AABB accreditation in early 2013.
Subscription fees consist of two components -- processing fee (RMB6,800) & annual storage fee (RMB860/year). A mandatory medical insurance program provided by a third party insurer is bundled with CCBC’s service package for an additional cost. As such gross annual storage payment made by client is RMB980/year